BMC Cancer

official impact factor 3.15

Open Access

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Dirk Vordermark*, Klemens Ruprecht, Peter Rieckmann, Wolfgang Roggendorf, Giles H Vince, Monika Warmuth-Metz, Oliver Kölbl and Michael Flentje

BMC Cancer 2006, 6:247 doi:10.1186/1471-2407-6-247

Accesses  

  • Last 30 days: 134 accesses
  • Last 365 days: 1246 accesses
  • All time: 6375 accesses